医药魔方 / 最新资讯 / 正文

致敬医药界的创业女神!

医药魔方 医药魔方 来源:医药魔方
2019-03-09
医药企业家
原文

医药行业一直是男性主导的圈子。在这个瞬息万变的时代,女性如何在浪潮之巅占有一席之地?比起朝九晚五的工作,创业是一项没有上班下班概念的事业。能在这个领域身经百战的女性,需要非一般的智慧与特有的魅力 。


今天是女神节,让我们细数当今中国生物医药领域杰出的女企业家,向这些创业女神致敬!(备注:排名不分先后,以姓名的首字母排序。)


曹晓春 泰格医药

曹晓春,泰格医药联合创始人、董事、执行副总裁、 董事会秘书、思默医药总经理、望吉健康总经理。作为公司联合创始人和主要管理层,协助泰格医药总裁一起管理泰格医药集团整体事务,分管集团人力资源、行政、政府事务、PR、CSR等职能部门。全面负责杭州思默医药科技有限公司日常工作。她毕业于浙江中医药大学中医专业,浙江大学药学院药学硕士,执业药师,高级工程师。


杜莹  再鼎医药

杜莹,再鼎医药(上海)有限公司的董事长。在创立再鼎医药之前,杜莹曾在红杉资本中国担任医疗投资总经理。从2001年到2011年,担任和记黄埔医药的创始人兼首席执行官。毕业于辛辛那提大学的生物化学专业。


范敏华  普利制药

范敏华,普利制药董事长、总经理。普利制药“地氯雷他定干混悬剂及其制备方法”、“一种地氯雷他定分散片及其制备方法”、“一种双氯芬酸钠微丸制剂及其制备方法”、“一种马来酸曲美布汀片及其制备方法”、“马来酸曲美布汀干混悬剂及其制备方法”等发明专利的发明人,主持了普利制药更昔洛韦钠冻干粉针剂及原料药等产品的 FDA、欧盟及 WHO 的cGMP(GMP)认证。范敏华女士还是中国药科大学硕士生导师。


冯宇霞,昭衍新药

冯宇霞,昭衍新药董事长,药理、毒理研究专家,主要从事药物临床前安全性评价研究。在她的带领下,昭衍主要为江苏省、全国及国际医药企业和研究机构提供主要包括研发项目设计个性化方案、药物筛选、药效学研究、药代动力学研究、安全性评价和临床试验以及注册服务的一条龙外包服务。毕业于中国人民解放军军事医学科学院药理学专业,获硕士学位。


黄纯莹 东曜药业

黄纯莹,东曜药业总经理,毕业于台北医学大学药学系。东曜药业有限公司创立于2010年7月,是一家专业从事抗肿瘤新药研发、生产和市场营销的高新技术企业,公司产品包括单克隆抗体及抗体偶联药物、溶瘤病毒制品以及特殊剂型抗癌药物等。


雷菊芳 西藏奇正药业

雷菊芳,现任西藏奇正藏药股份有限公司董事长、总经理。1977年毕业于西安交通大学,真空物理专业学士,高级工程师。上市世纪90年代,雷菊芳选择在平均海拔4000米以上的青藏高原发展事业,不遗余力地推动传统医药现代化,为民族药的发展奔走呼吁,带领藏药在中国医药市场占有一席之地。

 

李坦 海普瑞

李坦(左一),1987年7月毕业于四川大学化学系。1987年8月在安徽省石油化学工业厅教育处工作,1992年7月进入重庆通达,先后担任副总工程师、副总经理,1998年4月起进入海普瑞实业工作,现任本公司董事、副总经理,金田土科技执行董事、多普乐实业董事、多普生生物技术董事长。 


廖国娟 金唯智

廖国娟博士,GENEWIZ联合创始人,首席执行官,国家“千人计划"专家。南开大学生物化学本科,清华大学生物化学硕士,纽约州立大学石溪分校生物化学与细胞生物学博士,随后在哥伦比亚大学完成了生物化学和细胞生物学博士后研究。1999年,伴随着人类基因组计划的实施,廖国娟博士与孙中平博士在美国联合创办GENEWIZ(金唯智)。公司现已成为全球基因组学技术服务市场的领先企业之一,在全球多个国家运营着15个基因组实验室,为包括30位诺贝尔获奖者在内的数万名全球研究人员提供研究服务。


廖晓伶  Immune-Onc Therapeutics

廖晓伶博士,Immune-Onc Therapeutics联合创始人、总裁兼CEO。北京大学生化专业毕业,通过CUSBEA选拔留学美国,在Brandeis布兰迪斯大学获得博士学位,师从2017年生理学和医学诺贝尔奖得主之一 Michael Rosbash。曾任职于美国第一个生物技术公司Genentech近14年,主管早期药物开发。


唐南珊 Ansun制药

唐南珊博士,现任Ansun生物制药CEO,该公司由元明资本与方圆基金联共同投资,致力于开发新一代抗击流感病毒和副流感病毒的药物,其产品已获得FDA的“突破性疗法”认证。祖籍吴江,早年毕业于哈佛大学,取得生物化学和哲学博士学位,在2008年《福布斯》25位知名美籍华人中排名第一。她是活跃在当今世界生物制药业界的女杰,也是休斯敦Tanox公司创始人,后者于2006年被Genentech公司以9.19亿美元收购。


王锡娟 康辰药业 

王锡娟女士,北京康辰药业股份有限公司董事长。曾担任北京邮电医院技师、北京卫伦医药开发公司总经理、北京蓉生医药科技有限公司董事长等职务;现担任康辰医药董事长、辽宁康辰董事、沐仁投资董事长、康辰科技执行董事兼经理、药物研究院负责人、国药康辰董事等职务。


吴幼玲 特瑞思药业

浙江特瑞思药业股份有限公司总裁/董事长,国家千人计划特聘专家和南太湖精英计划领军人才,是科技部重大新药创制专项、国家发改委重大建设项目等课题负责人。在蛋白药物的分析鉴定、单抗药物的工艺开发和药学研究、药物的法规注册方面有很深的造诣,主导和参与了美国第一个上市的单抗偶联药物Brentuximab的开发。


夏瑜 康方生物

夏瑜,中山康方生物共同创始人,现任公司董事长,总裁兼CEO。曾任职德国拜耳、美国PDL生物制药(现雅培制药),美国CeleraGenomics等欧美制药公司,负责或参与了多个新药的临床前研究,抗体新药的生产工艺开发,工艺放大,技术转化和抗体的GMP生产,以及FDA临床试验批报。夏瑜博士自2008年4月回国后,曾任职中美冠科生物技术有限公司高级副总裁并兼任太仓冠科生物分析检测有限公司董事及总经理。


杨璐菡 启函生物科技

杨璐菡,启函生物创始人,CEO。2008年本科毕业于北京大学,曾因第一个利用CRISPR-Cas9技术修改细胞基因组和领导eGenesis,而被福布斯杂志评为2014年30岁以下30个科学医疗领域(30 under 30)领军人物之一。启函生物是一家基因编辑器官移植技术研发商,致力于使用基因编辑技术来获取可用于人体移植的异种细胞、组织和器官,解决器官移植供体短缺的问题。


叶英  力品药业 

叶英,力品药业(厦门)有限公司创始人、董事长。叶英于2013年创办了力品药业,引进和培养了一批与国际接轨的高科技制药人才,搭建了拥有自主国际专利的口腔黏膜给药技术平台以及符合产业化规模要求的缓控释制剂技术平台,并运用核心技术平台开发了治疗老年痴呆、少儿癫痫、少儿多动症、癌症患者止吐等领域的老年及小儿用药。


张仁华 瑞康医药

张仁华,1966年出生,大专学历,药剂师。历任烟台山医院团总支书记,山东瑞康药业总经理,瑞康配送总经理,现任本公司副董事长兼总经理,山东省人大代表。


赵宁,药明康德

赵宁,现任药明康德集团董事、公司高级运营副总裁及全球人力资源负责人。于2004年回国,并加入药明康德,担任分析服务副总裁以及分析服务首席顾问,在此期间建立了从化学分析到药物分析再到生物分析以及生产的质量检验的一体化的平台。


郑翔玲 正大天晴

郑翔玲,正大制药集团总裁、泰德制药董事长。郑翔玲是中国生物制药主席谢炳妻子,郑翔玲曾于2005年1月出任中国生物制药执行董事,2015年11月中国生物制药发布公告称,郑因健康原因辞任公司董事职务。2017年4月10日,中国生物制药发布公告,郑翔玲已获委任为公司执行董事、董事会副主席及执行董事委员会成员。郑翔玲透过本身的权益以及于正大百年集团有限公司及Remarkable Industries Limited的权益合共持有约18.63亿股公司股份。


钟慧娟 豪森生物

钟慧娟,汉族,硕士,江苏豪森医药集团有限公司总裁。中国优秀女企业家、中国杰出创业女性、江苏省杰出民营企业家、江苏省三八红旗手、江苏省十大杰出青年企业家、江苏省十佳环保女企业家。豪森药业控股股东为主席、执行董事及创始人。


机器翻译

The pharmaceutical industry has always been male-dominated.In this rapidly changing era, how do women have a place at the top of the wave?Entrepreneurship is a career without the concept of going to work rather than nine to five.Women Who are able to fight in this field need extraordinary wisdom and charm.

Today is the Goddess Festival. Let us count the outstanding female entrepreneurs in the Field of biomedicine in China today and pay tribute to these entrepreneurial goddesses! Note: Rank in no particular order, with the initials of the names.)

Cao Xiaochun Taige Medicine

Cao Xiaochun, co-founder of Tiger Pharmaceuticals. Director. Executive Vice President. Board Secretary. General Manager of Simer Pharmaceuticals. General Manager of Wangji Health. As co-founder and principal management of the company To help the president of Tiger Pharmaceuticals manage the overall affairs of Tiger Pharmaceutical Group and manage the Group's human resources. Administration.Government affairs.PR.CSR and other functional departments. Technology Co., Ltd. Daily work. She graduated from Zhejiang University of Traditional Chinese Medicine, majoring in medicine, Zhejiang University School of Pharmacy, Master of Pharmacy, licensed pharmacist, senior engineer.

Du Ying Ding Pharmaceutical

Du Ying, Chairman of the Board of Ding Pharmaceutical (Shanghai) Co., Ltd. Prior to Ding Ding, Du Ying worked as a general manager of medical investment at Sequoia Capital China. From 2001 to 2011, he was the founder and CEO of Hutchison Whampoa Pharmaceuticals. Graduated from the University of Cincinnati with a degree in biochemistry.

Fan Minhua Puli Pharmaceuticals

Fan Minhua, Chairman, Puli Pharmaceuticals. General Manager.Puli Pharmaceutical "Desloratadine Dry Suspension and Preparation Method"."A Desloratadine Dispersible Tablet And its Preparation". "A Trimebutine Maleate Tablet and the Preparation Method". The inventor of the invention patent such as "Trimebutine Maleate Dry Suspension and Preparation Method" chaired the FDA Of the products of Puli Pharmaceutical, ganciclov Ir sodium lyophilized powder for injection and API.CGMP (GMP) certification by the European Union and WHO.Ms. Fan Minhua is also a master's tutor of China Pharmaceutical University.

Feng Yuxia, Zhao Yanxin

>

Feng Yuxia, Chairman of Zhaoyan New Drugs, Pharmacology. Toxicology research expert, mainly engaged in preclinical safety evaluation of drugs. Under her leadership, Zhao Yan is mainly in Jiangsu Province. National and international pharmaceutical companies and research The organization provides a personalization program including R&D project design. Drug screening. Pharmacodynamic studies. Pharmacodynamic studies. Safety evaluation and clinical trial as well as registration service outsourcing services. He graduated from the Academy of Military Medical Sciences of the Chinese People's Liberation Army with a Master's degree in Pharmacology.

Huang Chunying TOT Pharmaceutical

Huang Chunying, East General Manager of Peony Pharmaceutical, graduated from the Department of Pharmacy, Taipei Medical University. TOT Pharmaceutical Co., Ltd. was founded in July 2010, is a professional engaged In anti-tumor drug research and development. High-tech enterprises in production and marketing, the company's products include monoclonal antibodies and antibody-conjugated drugs. Oncolytic virus products and special anti-cancer drugs, etc.

Lei Jufang Zangqizheng Pharmaceutical

Lei Jufang, current chairman of Tibet General Manager of Qizheng Tibetan Medicine Co., Ltd. Graduated from Xi'an Jiaotong University in 1977 The Bachelor of Vacuum Physics, Senior Engineer. Launched in the 1990s, Lei Jufang chose to develop in the Tibetan Plateau at an average altitude of 4000 meters above the Tibetan Plateau, spared no effort to promote the modernization of traditional medicine, for the development of Ethnic medicine to run the call, leading Tibetan medicine in the Chinese pharmaceutical market has a place.

Ritanhead

Li Tan (first from left) graduated from the Department of Chemistry of Sichuan University in July 1987. He worked in the Education Department of the Department of Petrochemical Industry of Anhui Province in August 1987. He entered Chongqing Tongda in July 1992 and served as the vice president. Engineer. Deputy General Manager, he has been involved in Haipu Rui Industrial since April 1998. He is currently a director of the Company. Deputy General Manager, Executive Director of Jintiantu Technology. Director of Doppler Industries. Chairman of Dopson Biotechnology.

< p>

Liao Guojuan Jin Weizhi

Dr. Liao Guojuan, co-founder and CEO of GENEWIZ, National “Thousand Talents Program”. He completed his postdoctoral studies in biochemistry and cell biology at Columbia University.In 1999, with the implementation Of the Human Genome Project, Dr. Liao Guojuan and Dr. Sun Zhongping co-founded GENEWIZ in the United States. The company is now one of the world's leading providers of genomics technology services, operating 15 genomes in multiple countries around the world. Laboratory, providing research services to tens of thousands of global researchers including 30 Nobel laureates.

Liao Xiaoling Immune-Onc Therapeutics

Dr. Liao Xiaotong, co-founder of Immune-Onc Therapeutics. President and CEO. He graduated from Peking University with a major in biochemistry and was selected to study in the United States through CUSBEA. He received his Ph. D. from Brandeis Brandeis University and studied under Michael Rosbash, one of the Nobel Prize winners in physiology and medicine in 2017. worked in the US Genentech, a biotechnology company, has been in charge of early drug development for nearly 14 years.

Annan Pharmaceuticals, Tang Nanshan

Dr. Tang Nanshan, currently CEO of Ansun Biopharmaceuticals, is a joint venture of Yuanming Capital and Fang Yuan Fund to develop a new generation of drugs against influenza and parainfluenza viruses, whose products have been accredited by the FDA as "Breakthrough Therapies". A native of Wu Jiang, who graduated from Harvard University in early years, obtained biochemistry and Doctor of Philosophy, ranked first among the 25 well-known American Chinese in Forbes in 2008. She is a woman active in the biopharmaceutical industry today and founder of Houston's Tanox, which was acquired by Genentech in 2006 for $919 million.

Wang Xijuan Kangchen Pharmaceutical

Ms. Wang Xijuan, Chairman of Beijing Kangchen Pharmaceutical Co., Ltd. was a technician at Beijing Post and Telecommunications Hospital. Beijing Weilun Pharmaceutical General Manager of Development Company. Chairman of Beijing Rongsheng Pharmaceutical Technology Co., Ltd., etc. Now serves as Chairman of Kangchen Pharmaceutical. Director of Liaoning Kangchen. Chairman of Ren Investment. Executive director and manager of kang chen technology. Head of the Pharmaceutical Research Institute. Director of Sinopharm Kangchen et al.

Wu Youling Treth Pharmaceutical

< p>

Zhejiang Teresi Pharmaceutical Co., Ltd. President/Chairman, National Thousand Talents Program Specialist and South Taihu Elite Program Leaders, is a major new drug creation project of the Ministry of Science and Technology. National development and reform commission Analysis and identification of protein drugs. Process development and pharmaceutical research of monoclonal antibodies. There is a deep understanding of the regulatory registration of drugs, leading and participating in the first monoclonal antibody coupling in the United States. Development of the drug Brentuximab.

Xia Yu Kang Fang Biological

Xia Yu, co-founder of Zhongshan Kangfang Biology, is The current chairman, president and CEO of the company. He served in Bayer, Germany. PDL Biopharmaceuticals (now Abbott Laboratories), US-based CeleraGenomics and other European and American pharmaceutical companies, responsible for or involved in the preclinical study of several new drugs. , production process development of new antibody drugs, process amplification, technology conversion and GMP production of antibodies, and FDA clinical trial approval. Since his return to China in April 2008, Dr. Xia Yu has served as Senior Vice President of China-US Guanke Biotechnology Co., Ltd. and concurrently served as Director and General Manager of Taicang Guanke Bioanalytical Testing Co., Ltd.

Yang Yuqiu Biotechnology

Yang Wei, founder of Kaixin Bio, CEO. Graduated from Peking University in 2008. He was named the first 30 scientific medical students under the age of 30 in 2014 by Forbes magazine for the first use of CRISPR-Cas9 technology to modify the cell genome and lead eGenesis. One of the leading figures in the field (30 under 30). Kaixin Bio is a genetically edited organ transplant technology developer dedicated to using genetic editing techniques to obtain xenogeneic cells, tissues and organs that can be used for human transplantation, and to address the shortage of organ transplant donors. Problem.

Ye Yingli Pharmaceuticals

Ye Ying, Founder of Lipin Pharmaceutical ( Xiamen) Chairman of Co., Ltd. Ye Ying in 2013 Established Lipin Pharmaceutical Co., Ltd., introduced and cultivated a group of high-tech pharmaceutical talents in line with international standards, built an oral mucosal drug delivery technology platform with independent international patents, and a technology platform for slow and controlled release preparations that meets the requirements of industrial scale. Epilepsy in children.ADHD in children.Antiemetic drugs for elderly and children in cancer patients.

Zhang Renhua Ruikang Medicine

Zhang Renhua, born in 1966, college degree, pharmacist. He served as secretary of the General Branch of Yantaishan Hospital, general manager of Shandong Ruikang Pharmaceutical, general manager of Ruikang Distribution, and now serves as vice chairman and general manager of the company, Shandong Province NPC Deputies.

Zhao Ning, WuXi PharmaTech

Zhao Ning, currently a director Of WuXi AppTec. Vice President of Analytical Services and Principal Advisor of Analytical Services, during which he established a platform for integration from chemical Analysis to pharmaceutical analysis to bioanalysis and quality inspection of production.

Zheng Xiangling Zhengda Qingqing

Zheng Xiangling, President of Zhengda Pharmaceutical Group. Chairman of TANDBERG Pharmaceuticals. Zheng Xiangling is the wife of Xie Bing, chairman of China Biopharmaceutical. Zheng Xiangling was the executive director of China Biopharmaceutical in January 2005. On April 10, 2017, China Biopharma announced that Zheng Xiangling has been appointed as the executive director of the company. Vice Chairman of the Board and a member of the Executive Board Committee. Zheng Xiangling holds approximately 1.863 billion shares of the company through its own interests and interests in Zhengda Centennial Group Co., Ltd. and Remarkable Industries Limited.

< p>Zhong Huijuanhaosen Biological

Huijuan Zhong, Han, Master, President of Jiangsu Haosen Pharmaceutical Group Co., Ltd.Excellent female entrepreneur in China. China's outstanding entrepreneurial women. Jiangsu outstanding private entrepreneurs. The red flag man of jiangsu province. Jiangsu's top ten outstanding young enterprises Home. Top Ten Environmental Entrepreneur of Jiangsu Province. The controlling shareholder of Haosen Pharmaceutical is the chairman. Executive Director and Founder.

扫码实时看更多精彩文章

版权及免责声明 本文由医药魔方原创,版权归医药魔方所有。未经许可,严禁任何媒体或个人以任何形式摘编、改写、复制、转载本文内容。对于恶意侵权行为,医药魔方保留采用法律手段追究的权利。媒体内容及商务合作请联系医药魔方工作人员(微信号:medicube)

魔方微信公众号